# Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

> **NCT00387959** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 17 (actual)

## Conditions studied

- Leukemia
- Lymphoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** rituximab
- **DRUG:** cyclophosphamide
- **DRUG:** cyclosporine
- **DRUG:** fludarabine phosphate
- **DRUG:** mycophenolate mofetil
- **PROCEDURE:** allogeneic hematopoietic stem cell transplantation
- **PROCEDURE:** umbilical cord blood transplantation
- **RADIATION:** total-body irradiation

## Key facts

- **NCT ID:** NCT00387959
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2016-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00387959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00387959, "Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00387959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*